Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/12/2003 First Published: 4/23/2003


1.		Phase I/II Study of Photodynamic Therapy Using HPPH in Patients With Obstructive Esophageal Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				RPCI-DS-9701 NCT00060268

Last Modified: 6/17/2008 First Published: 1/20/2006


2.		Phase II Randomized Study of Photodynamic Therapy Using HPPH in Patients With High-Grade Dysplasia, Carcinoma In Situ, or Early Intramucosal Adenocarcinoma of the Esophagus and Barrett's Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Temporarily closed				18 and over				Other				RPCI-I-30404 NCT00281736

Last Modified: 5/2/2007 First Published: 6/1/2001


3.		Phase I Study of Photodynamic Therapy Using HPPH in Patients With Basal Cell Skin Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				Over 18				NCI				RPCI-DS-95-34 NCI-G01-1953, NCT00017485

Last Modified: 1/1/2003 First Published: 10/1/2001


4.		Phase I Study of Photodynamic Therapy With HPPH in Patients With Early Stage or Centrally Obstructing Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				RPCI-RP-0005 NCI-G01-2023, NCT00025571

Select All on One Page